CD30 and the NPM‐ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma
Norihiro Awaya(Fred Hutch Cancer Center), Toru Abe(Social Insurance Saitama Chuo Hospital), Hitoshi TAKEUCHI(Saitama Medical University), Tamihiro Kamata(Keio University), Tsutomu Takeuchi(Keio University), Shigehisa Mori(Social Insurance Saitama Chuo Hospital), Shigeo Mori(Tokyo University of Science), Yasuo Sugano(keiyu Hospital)
Cited by 26
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|413